2018 Annual Meeting | C208 - Assessment of Rapidly Progressive Dementias II: Neurodegenerative Diseases and Prion Diseases

Date Thursday 04/26/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michael D. Geschwind, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnosis of neurodegenerative diseases and infectious causes of RPD and the clinical presentation and evaluation of the more common conditions.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Tracks Advanced Practice Provider

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation, Panel Discussion

Event Timeline
03:30 PM - 04:20 PM	Speaker	Neurodegenerative Diseases Presenting as Rapidly Progressive Dementia Bradley F. Boeve, MD, FAAN
04:20 PM - 05:10 PM	Speaker	Assessment of Rapidly Progressive Dementias: Prion Diseases Michael D. Geschwind, MD, PhD, FAAN
05:10 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.